脑膜瘤占全部原发颅内肿瘤的15％～20％,产生于珠网膜细胞且多无组织病理学体征,但其病死率很高。据报道,手术死亡率高达 14.3％,复发率可达 50％,并取决于切除程度和组织病理学特征。寻找手术以外的辅助或替代疗法已显示具有放疗和放射手术疗法的有益效应。抗孕酮治疗亦有效。重组α-干扰素在体外可抑制经培养的人脑膜瘤细胞的生长,作者将本品用于一不能手术的复发 Meningiomas account for 15% to 20% of all primary intracranial tumors and are produced in the glomerular cells and have many histopathological signs, but their mortality is high. It has been reported that the operative mortality rate is as high as 14.3% and the recurrence rate is up to 50%, depending on the degree of resection and the histopathological features. Finding ancillary or alternative therapies other than surgery has been shown to have the beneficial effects of radiotherapy and radiosurgery. Anti-progesterone treatment is also effective. Recombinant alpha-interferon in vitro can inhibit the growth of cultured human meningioma cells, the author of this product for an inoperable recurrence